Subscribe to RSS
DOI: 10.1055/s-0044-1785487
Epidemiology, Etiology, and Pathophysiology of Pulmonary Embolism
Abstract
Over the last 20 years, there has been a progressive increase in the incidence of pulmonary embolism (PE) diagnosis in the United States, Europe, and Australia. Increased use of computed tomography pulmonary angiography has likely contributed in part to this rising incidence. However, it is pertinent to note that the burden of comorbidities associated with PE, such as malignancy, obesity, and advanced age, has also increased over the past 20 years. Time-trend analysis in North American, European, and Asian populations suggests that mortality rates associated with PE have been declining. The reported improved survival rates in PE over the past 20 years are likely, at least in part, to be the result of better adherence to guidelines, improved risk stratification, and enhanced treatment. Factors contributing to the development of venous thromboembolism (VTE) include stasis of blood, hypercoagulability, endothelial injury, and inflammation. In 70 to 80% of cases of PE, the thrombi embolizes from the proximal deep veins of the lower extremities and pelvis. Strong risk factors for VTE include lower extremity fractures and surgeries, major trauma, and hospitalization within the previous 3 months for acute myocardial infarction or heart failure with atrial fibrillation. Acute PE causes several pathophysiological responses including hypoxemia and right ventricle (RV) failure. The latter is a result of pulmonary artery occlusion and associated vasoconstriction. Hemodynamic compromise from RV failure is the principal cause of poor outcome in patients with acute PE.
Keywords
pulmonary embolism - thromboembolic disease - venous thrombosis - epidemiology - pathophysiology - etiology - risk factorsPublication History
Article published online:
12 April 2024
© 2024. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
-
References
- 1 Thompson BT, Kabrhel C. Epidemiology and pathogenesis of acute pulmonary embolism in adults. Accessed December 16, 2023 at: www.uptodate.com/contents/epidemiology-and-pathogenesis-of-acute-pulmonary-embolism-in-adults
- 2 Freund Y, Cohen-Aubart F, Bloom B. Acute pulmonary embolism: a review. JAMA 2022; 328 (13) 1336-1345
- 3 Tsao CW, Aday AW, Almarzooq ZI. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation 2023; 147 (08) e93-e621
- 4 Sonne-Holm E, Kjærgaard J, Bang LE, Fosbøl E, Carlsen J, Winther-Jensen M. Pulmonary embolism: age specific temporal trends in incidence and mortality in Denmark 1999-2018. Thromb Res 2022; 210: 12-19
- 5 de Miguel-Díez J, Jiménez-García R, Jiménez D. et al. Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J 2014; 44 (04) 942-950
- 6 Dentali F, Ageno W, Pomero F, Fenoglio L, Squizzato A, Bonzini M. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost 2016; 115 (02) 399-405
- 7 Shiraev TP, Omari A, Rushworth RL. Trends in pulmonary embolism morbidity and mortality in Australia. Thromb Res 2013; 132 (01) 19-25
- 8 Population figures. Statistics Denmark, StatBank Denmark, Accessed December 16, 2023 at: https://www.dst.dk/en/Statistik/emner/borgere/befolkning/befolkningstal
- 9 Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 2013; 347: f3368
- 10 Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171 (09) 831-837
- 11 Dobler CC. Overdiagnosis of pulmonary embolism: definition, causes and implications. Breathe (Sheff) 2019; 15 (01) 46-53
- 12 Turetz M, Sideris AT, Friedman OA, Triphathi N, Horowitz JM. Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin Intervent Radiol 2018; 35 (02) 92-98
- 13 Russell C, Keshavamurthy S, Saha S. Classification and stratification of pulmonary embolisms. Int J Angiol 2022; 31 (03) 162-165
- 14 Fitzmaurice C, Abate D, Abbasi N. et al; Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 2019; 5 (12) 1749-1768
- 15 Jaacks LM, Vandevijvere S, Pan A. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 2019; 7 (03) 231-240
- 16 Adult obesity facts. Centers for Disease Control and Prevention, U.S. Department of Health & Human Services. Accessed December 16, 2023 at: https://www.cdc.gov/obesity/data/adult.html
- 17 Konstantinides SV, Meyer G, Becattini C. et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 2020; 41 (04) 543-603
- 18 Barco S, Valerio L, Ageno W. et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med 2021; 9 (01) 33-42
- 19 Hobohm L, Sebastian T, Valerio L. et al. [Trends in mortality related to pulmonary embolism in the DACH countries]. Med Klin Intensivmed Notf Med 2022; 117 (06) 428-438
- 20 Piazza G, Campia U, Hurwitz S. et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol 2020; 76 (18) 2060-2072
- 21 Voci D, Fedeli U, Farmakis IT. et al. Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: an epidemiological analysis of data from an Italian high-risk area. Thromb Res 2022; 212: 44-50
- 22 McBane II RD. Thromboembolism and the pandemic. J Am Coll Cardiol 2020; 76 (18) 2073-2075
- 23 Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol 2008; 143 (02) 180-190
- 24 Bauer KA, Lip GYH. Overview of the causes of venous thrombosis. Accessed December 15, 2023 at: www.uptodate.com/contents/overview-of-the-causes-of-venous-thrombosis
- 25 Nachman D, Pollack A, Herzog E. Epidemiology, pathophysiology and predisposing factors of pulmonary embolism and deep vein thrombosis. In: Pulmonary Embolism. Switzerland: Springer Nature; 2022. ; Chapter 2, 22–41
- 26 Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet 2021; 398 (10294): 64-77
- 27 Shah IK, Merfeld JM, Chun J, Tak T. Pathophysiology and management of pulmonary embolism. Int J Angiol 2022; 31 (03) 143-149
- 28 Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism. J Thromb Haemost 2013; 11 (03) 412-422
- 29 Huisman MV, Barco S, Cannegieter SC. et al. Pulmonary embolism. Nat Rev Dis Primers 2018; 4: 18028
- 30 Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23, suppl 1): I9-I16
- 31 Desmarais S, de Moerloose P, Reber G, Minazio P, Perrier A, Bounameaux H. Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996; 347 (9012) 1374-1375
- 32 Marik PE. Venous thromboembolism in pregnancy. Clin Chest Med 2010; 31 (04) 731-740
- 33 Steffen LM, Cushman M, Peacock JM. et al. Metabolic syndrome and risk of venous thromboembolism: longitudinal investigation of thromboembolism etiology. J Thromb Haemost 2009; 7 (05) 746-751
- 34 Akrivou D, Perlepe G, Kirgou P, Gourgoulianis KI, Malli F. Pathophysiological aspects of aging in venous thromboembolism: an update. Medicina (Kaunas) 2022; 58 (08) 1078-1092
- 35 Spencer FA, Emery C, Lessard D. et al. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21 (07) 722-727
- 36 McIntyre KM, Sasahara AA. The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease. Am J Cardiol 1971; 28 (03) 288-294
- 37 Smulders YM. Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction. Cardiovasc Res 2000; 48 (01) 23-33